Compare · 2 funds side by side · dividends reinvested

CURE and SPY

CUREDirexion×SPYSPDR×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$17,099SPY · best of the two

02 / 04

CURE and SPY, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

State Street SPDR S&P 500 ETFLow-Cost Core · S&P 5000.09%1.03%+8.3%+9.7%+22.0%+11.3%−8.9%13.6%$819B1.4

Direxion Daily Healthcare Bull 3X ETFLeveraged · 3x0.94%0.76%+50.8%+81.4%+29.9%+7.9%−31.1%49.4%$217M1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 5, 2026 · returns include dividends · since: CURE 2011 · SPY 1993

Head to Head

Swap sides Versus in desk

Head to Head

Direxion Daily Healthcare Bull 3X ETF · $217M$14,647

CURE

SPY

State Street SPDR S&P 500 ETF · $819B$17,099

$10,000 five years ago, dividends reinvested · they hold 10.4% in common

CUREMeasureSPY

+50.8%Year to dateJan 1 → Nov 5+8.3%

+81.4%1 yearTotal return+9.7%

+29.9%3 years · per year$10,000 became $21,930 · $18,174+22.0%

+7.9%5 years · per year$10,000 became $14,647 · $17,099+11.3%

0.94%Expense ratio$94 · $9 a year on $10k · lower is better0.09%

0.76%Trailing 12-mo yield$76 · $103 a year on $10k1.03%

−31.1%Worst dropSmaller is better−8.9%

49.4%VolatilityLower is calmer13.6%

CURESPY Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5SPY wins

End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

CURE vs SPY: Top 5 Holdings

Today

CURE

8.9%in top 5

SPY

in top 527.7%

CUREStockSPY

not top 5AAPL7.7%

not top 5NVDA7.3%

not top 5MSFT6.2%

not top 5AMZN3.9%

3.3%LLYnot top 5

not top 5GOOGL2.6%

1.9%JNJnot top 5

1.5%ABBVnot top 5

1.1%MRKnot top 5

1.1%UNHnot top 5

Held in common10.4%

End-of-day Nov 5, 2026 · share of each fund

CURE vs SPY Returns, Every Period

DirexionCURE

+7.9%

5 years, per year

SPYSPDR

+11.3%

5 years, per year

CURESPYFaded: behind in that period

3–1CURE wins

End-of-day Nov 5, 2026 · dividends in · faded = behind in that period

Leveraged vs Core: CURE vs SPY

YTD

DirexionCURE

+50.8%

SPYSPDR

+8.3%

+50.8%Year to date+8.3%

−31.1%Worst drop · 1Y−8.9%

49.4%Volatility · 1Y13.6%

0.8%Yield1.0%

$217MAssets$819B

3–1SPY wins

End-of-day Nov 5, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: CURE, SPY

Today

0.09%lowest, SPY

FundExpense ratioFee$10k

SPY0.09%$9

CURE0.94%$94

End-of-day Nov 5, 2026 · fee on $10,000 a year

Yields: CURE, SPY

1.03%highest, SPY

FundTrailing yieldYield$10k

SPY1.03%$103

CURE0.76%$76

End-of-day Nov 5, 2026 · trailing 12-month yield

Income After Fees on $10,000

$94most kept, SPY

SPY$103 − $9 = $94

CURE$76 − $94 = −$18

KeptFee

End-of-day Nov 5, 2026 · yield in dollars minus the fee

Overlap: CURE, SPY

Today

10.4%most shared, CURE and SPY

CURESPY

CURE—10.4%

SPY10.4%—

End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+81.4%CURE, at 49.4% volatility

SPYWorst drop−8.9%13.6% vol

CUREWorst drop−31.1%49.4% vol

End-of-day Nov 5, 2026 · up and left is better

Paid More vs Made More

YTD

SPYCURE

+8.3%Year to date+50.8%

1.0%Yield0.8%

+9.7%Past year+81.4%

0.09%Fee0.94%

2–2level

End-of-day Nov 5, 2026

Popular Pairs Near These Two

SPYM vs SPY

YTD

SPDRSPYM

+8.4%

SPYSPDR

+8.3%

+8.4%Year to date+8.3%

1.1%Yield1.0%

$182BAssets$819B

2–0SPYM wins

End-of-day Nov 5, 2026

SCHD vs VIG

YTD

SchwabSCHD

+32.3%

VIGVanguard

+12.5%

+32.3%Year to date+12.5%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 5, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+5.2%

+8.5%Year to date+5.2%

12.2%Yield8.1%

$42.6BAssets$46.8B

2–0JEPQ wins

End-of-day Nov 5, 2026